Toctino (alitretinoin) / Basilea, GSK  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Toctino (alitretinoin) / Basilea
2021-003543-16: A 24 week trial to compare the efficacy and safety of delgocitinib cream 20 mg/g twice-daily with alitretinoin capsules once-daily in adult participants with severe chronic hand eczema

Not yet recruiting
3
510
Europe
Delgocitinib, [----], [0000000], [-----------------------], Cream, Capsule, soft, Toctino
LEO Pharma A/S, LEO PHARMA A/S, LEO Pharma A/S
Chronic Hand Eczema, Severe Hand Eczema, Diseases [C] - Skin and Connective Tissue Diseases [C17]
 
 
NCT05259722: A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

Completed
3
513
Europe, Canada
Delgocitinib, Toctino
LEO Pharma
Chronic Hand Eczema
11/23
12/23

Download Options